Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Meghann C. Ryan"'
Autor:
Peter Kochunov, Meghann C. Ryan, Qifan Yang, Kathryn S. Hatch, Alyssa Zhu, Sophia I. Thomopoulos, Neda Jahanshad, Lianne Schmaal, Paul M. Thompson, Shuo Chen, Xiaoming Du, Bhim M. Adhikari, Heather Bruce, Stephanie Hare, Eric L. Goldwaser, Mark D. Kvarta, Thomas E. Nichols, L. Elliot Hong
Publikováno v:
NeuroImage: Clinical, Vol 29, Iss , Pp 102574- (2021)
Neurological and psychiatric illnesses are associated with regional brain deficit patterns that bear unique signatures and capture illness-specific characteristics. The Regional Vulnerability Index (RVI) was developed to quantify brain similarity by
Externí odkaz:
https://doaj.org/article/8692a3ac71b54b57b3d2196227216365
Autor:
Linda Chang, Meghann C. Ryan, Huajun Liang, Xin Zhang, Eric Cunningham, Justin Wang, Eleanor Wilson, Edward H. Herskovits, Shyamasundaran Kottilil, Thomas M. Ernst
Publikováno v:
Neurology. 100:e2409-e2423
Autor:
Meghann C. Ryan, L. Elliot Hong, Kathryn S. Hatch, Si Gao, Shuo Chen, Krystl Haerian, Jingtao Wang, Eric L. Goldwaser, Xiaoming Du, Bhim M. Adhikari, Heather Bruce, Stephanie Hare, Mark D. Kvarta, Neda Jahanshad, Thomas E. Nichols, Paul M. Thompson, Peter Kochunov
Publikováno v:
Human Brain Mapping. 43:1997-2010
Severe mental illnesses (SMI) including major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia spectrum disorder (SSD) elevate accelerated brain aging risks. Cardio-metabolic disorders (CMD) are common comorbidities in SMI and nega
Autor:
Huajun Liang, Thomas Ernst, Kenichi Oishi, Meghann C. Ryan, Edward Herskovits, Eric Cunningham, Eleanor Wilson, Shyamasundaran Kottilil, Linda Chang
Publikováno v:
NeuroImmune Pharmacology and Therapeutics.
Objectives We aimed to compare brain white matter integrity in participants with post-COVID-19 conditions (PCC) and healthy controls. Methods We compared cognitive performance (NIH Toolbox®), psychiatric symptoms and diffusion tensor imaging (DTI) m
Autor:
Muhammad G. Saleh, Linda Chang, Huajun Liang, Meghann C. Ryan, Eric Cunningham, Jonathan Garner, Eleanor Wilson, Andrea R. Levine, Shyamasundaran Kottilil, Thomas Ernst
Publikováno v:
NeuroImmune Pharmacology and Therapeutics.
Objectives Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with lower plasma glutathione (GSH) levels due to oxidative stress. However, plasma levels may not reflect brain GSH levels. Individuals with post-acute seque
Autor:
Neda Jahanshad, Yimin Cui, Mark D. Kvarta, Heather Bruce, Stephanie M. Hare, Meghann C. Ryan, Eric L. Goldwaser, Kathryn S. Hatch, Theo G.M. van Erp, Baopeng Cao, Bhim M. Adhikari, Yunlong Tan, Xiaoming Du, Shuo Chen, Junchao Huang, Jessica A. Turner, Paul M. Thompson, Shuping Tan, Fengmei Fan, Peter Kochunov, Jinghui Tong, L. Elliot Hong
Publikováno v:
Human Brain Mapping
Patients with schizophrenia have patterns of brain deficits including reduced cortical thickness, subcortical gray matter volumes, and cerebral white matter integrity. We proposed the regional vulnerability index (RVI) to translate the results of Enh
Autor:
Carrie E. Bearden, Gianfranco Spalletta, Paul M. Thompson, Meghann C. Ryan, Liz Haddad, Fabrizio Piras, Gary Donohoe, Talia M. Nir, Peter Kochunov, David C. Glahn, Josselin Houenou, David F. Tate, Rajendra A. Morey, Odile A. van den Heuvel, L. Elliot Hong, Mark W. Logue, Pauline Favre, Laurena Holleran, Theo G.M. van Erp, Ole A. Andreassen, Sinead Kelly, Emily L. Dennis, Dan J. Stein, Yunlong Tan, Christopher R.K. Ching, Neda Jahanshad, Lianne Schmaal, Elisabeth A. Wilde, Laura S van Velzen, Jessica A. Turner, Julio E. Villalon-Reina, Dick J. Veltman
Publikováno v:
Kochunov, P, Hong, L E, Dennis, E L, Morey, R A, Tate, D F, Wilde, E A, Logue, M, Kelly, S, Donohoe, G, Favre, P, Houenou, J, Ching, C R K, Holleran, L, Andreassen, O A, van Velzen, L S, Schmaal, L, Villalón-Reina, J E, Bearden, C E, Piras, F, Spalletta, G, van den Heuvel, O A, Veltman, D J, Stein, D J, Ryan, M C, Tan, Y, van Erp, T G M, Turner, J A, Haddad, L, Nir, T M, Glahn, D C, Thompson, P M & Jahanshad, N 2022, ' ENIGMA-DTI : Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research ', Human Brain Mapping, vol. 43, no. 1, pp. 194-206 . https://doi.org/10.1002/hbm.24998
Human Brain Mapping
Human Brain Mapping
The ENIGMA‐DTI (diffusion tensor imaging) workgroup supports analyses that examine the effects of psychiatric, neurological, and developmental disorders on the white matter pathways of the human brain, as well as the effects of normal variation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1807a29555dc09cad8725b7b7c990bd
https://research.vumc.nl/en/publications/1f1cb2ba-1241-4d23-86ea-acaf5273f9f9
https://research.vumc.nl/en/publications/1f1cb2ba-1241-4d23-86ea-acaf5273f9f9
Autor:
Anya Savransky, Joshua Chiappelli, Peter Kochunov, Alan R. Shuldiner, Hongji Chen, L. Elliot Hong, Braxton D. Mitchell, Shuo Chen, Sulaiman Sheriff, Wyatt Marshall, Laura M. Rowland, Heather Bruce, Meghann C. Ryan, Andrew A. Maudsley, S. Andrea Wijtenburg
Publikováno v:
Proceedings of the National Academy of Sciences. 116:25243-25249
Cardiovascular risk factors such as dyslipidemia and hypertension increase the risk for white matter pathology and cognitive decline. We hypothesize that white matter levels of N-acetylaspartate (NAA), a chemical involved in the metabolic pathway for
Autor:
Shuping Tan, Fengmei Fan, Ping Zhang, Song Chen, Yimin Cui, Meghann C. Ryan, Laura M. Rowland, Anya Savransky, Eric L. Goldwaser, Xingguang Luo, Ying Yuan, Yanfang Zhou, Wei Feng, Joshua Chiappelli, Peter Kochunov, Fude Yang, Junchao Huang, Zhiren Wang, L. Elliot Hong, Yunlong Tan, Hongzhen Fan
Publikováno v:
Schizophr Bull
Although schizophrenia is a brain disorder, increasing evidence suggests that there may be body-wide involvement in this illness. However, direct evidence of brain structures involved in the presumed peripheral-central interaction in schizophrenia is
Autor:
Hemalatha Sampath, Yunlong Tan, Yanli Li, Paul M. Thompson, Meghann C. Ryan, Junchao Huang, Laura M. Rowland, Neda Jahanshad, Yun-Hui Wang, Xiaoming Du, Bhim M. Adhikari, Shuping Tan, Song Chen, Shuo Chen, Fengmei Fan, Yimin Cui, Anya Savransky, Wei Feng, Joshua Chiappelli, Peter Kochunov, Zhiren Wang, L. Elliot Hong, Fude Yang
Publikováno v:
Am J Psychiatry
Failure of antipsychotic medications to resolve symptoms in patients with schizophrenia creates a clinical challenge that is known as treatment resistance. The causes of treatment resistance are unknown, but it is associated with earlier age at onset